Current State and Challenges in Development of Targeted Therapies in Myelodysplastic Syndromes (MDS)

Overview of attention for article published in Hemato, April 2021

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
Good Attention Score compared to outputs of the same age (73rd percentile)
Above-average Attention Score compared to outputs of the same age and source (60th percentile)

Mentioned by

twitter: 8 X users

Readers on

mendeley: 8 Mendeley

So far, Altmetric has seen 9 X posts from 8 X users, with an upper bound of 56,718 followers.

RT @Hemato_MDPI: Now online @MDStanch, @TaylorJ_MD and colleagues from @SylvesterCancer review article "Current State and Challenges in Dev…

RT @TaylorJ_MD: Check out our new review! Thanks to help from co-authors and reviewers/editors. Exciting times in #MDS drug development! ⬇️…

RT @MDStanch: Always amazing to work with @TaylorJ_MD Congrats on your first pub @MatthewKarr8 👏👏 https://t.co/fCd1kBD5QK

This page shows the most recent X posts that mention this research output. Click here to find out how to access more activity, including 5 additional X posts.